Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
19%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
BBP
68
HOLDINGS
23%
ALSO IN CANC
CANC
56
HOLDINGS
25%
ALSO IN BBP
SECTOR DRIFT (BBP minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
IOVANCE BIOTHERAPEUTICS INC | 4.5% | 3.4% | 3.4% |
|
HALOZYME THERAPEUTICS INC | 2.0% | 3.2% | 2.0% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.9% | 1.9% | 1.9% |
|
BEIGENE LTD. SPONSORED ADR | 1.8% | 3.5% | 1.8% |
|
EXELIXIS INC | 1.4% | 3.3% | 1.4% |
BBP Overweight Relative to CANC
|
MODERNA, INC. | 4.7% |
|
OMEROS CORP | 2.8% |
|
INTREXON CORP | 2.3% |
|
XERIS PHARMACEUTICALS INC | 1.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.6% |
|
TARSUS PHARMACEUTICALS, INC. | 1.6% |
|
REGENERON PHARMACEUTICALS | 1.6% |
|
NOVAVAX INC | 1.5% |
|
LIGAND PHARMACEUTICALS-CL B | 1.5% |
|
ADMA BIOLOGICS, INC. | 1.5% |
BBP Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.5% |
|
MERCK & CO. INC. | -5.3% |
|
COGENT BIOSCIENCES INC | -4.8% |
|
ELI LILLY & CO | -4.7% |
 |
NOVARTIS AG | -3.9% |
 |
GENMAB A/S SPONSORED ADR | -3.7% |
|
ABBVIE INC | -3.6% |
|
BRISTOL-MYERS SQUIBB CO | -3.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -2.7% |
|
IDEAYA BIOSCIENCES, INC. | -2.6% |